Table 1.
Clinical and pathological characteristics of patients.
| Characteristics | Classification | Patients (n) | Patients (percent) |
|---|---|---|---|
| Age | <60 years | 201 | 38.7% |
| ≥60 years | 318 | 61.3% | |
| Gender | Male | 425 | 81.9% |
| Female | 94 | 18.1% | |
| Smoking | Ever | 253 | 48.7% |
| Never | 266 | 51.3% | |
| Drinking | Ever | 218 | 42.0% |
| Never | 301 | 58.0% | |
| Family history | Yes | 33 | 6.4% |
| No | 486 | 93.6% | |
| Location | Cervical | 39 | 7.5% |
| Upper | 34 | 6.6% | |
| Middle | 269 | 51.8% | |
| Lower | 177 | 34.1% | |
| Length | <4 cm | 270 | 52.0% |
| ≥4 cm | 249 | 48.0% | |
| Differentiation | GX | 16 | 3.1% |
| G1 | 100 | 19.3% | |
| G2 | 204 | 39.3% | |
| G3 | 199 | 38.3% | |
| T stage | Tis | 16 | 3.1% |
| T1 | 57 | 11.0% | |
| T2 | 152 | 29.3% | |
| T3 | 285 | 54.9% | |
| T4 | 9 | 1.7% | |
| LNM | Yes | 225 | 43.4% |
| No | 294 | 56.6% | |
| N stage | N0 | 294 | 56.6% |
| N1 | 130 | 25.0% | |
| N2 | 67 | 12.9% | |
| N3 | 28 | 5.4% | |
| TNM | I | 73 | 14.1% |
| II | 256 | 49.3% | |
| III | 190 | 36.6% | |
| Treatment | S | 308 | 59.3% |
| S + RT | 67 | 12.9% | |
| S + CT | 65 | 12.5% | |
| S + RCT | 79 | 15.2% | |
| BMI | <18.5 | 86 | 16.6% |
| 18.5~25 | 347 | 66.9% | |
| >25 | 86 | 16.6% | |
| Weight loss | No | 96 | 18.5% |
| A little | 89 | 17.1% | |
| Middle | 239 | 46.1% | |
| Much | 95 | 18.3% | |
| Hypertension | No | 410 | 79.0% |
| Yes | 109 | 21.0% | |
| Diabetes | No | 430 | 82.9% |
| Yes | 89 | 17.1% | |
| Dyslipidemia | No | 434 | 83.6% |
| Yes | 85 | 16.4% | |
| HDL | <0.9 | 49 | 9.4% |
| ≥0.9 | 470 | 90.6% | |
| TG | <1.7 | 475 | 91.5% |
| ≥1.7 | 44 | 8.5% | |
| MS | No | 466 | 89.8% |
| Yes | 53 | 10.2% |
Abbreviations: LNM, lymph node metastasis; S, surgery; RT, radiotherapy; CT, chemotherapy; CRT, chemoradiotherapy; BMI, Body Mass Index; HDL, high density lipoprotein; TG, triglyceride; MS, metabolic syndrome.